Romosozumab

Romosozumab Versus Denosumab in Glucocorticoid-induced Osteoporosis: an Extended Observation of a Randomized Controlled Trial at 48 Months

Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta

Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea

Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI

Combined Anabolic Therapy

Anabolic Therapy in Postmenopausal Osteoporosis

Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes

Romosozumab Use to Build Skeletal Integrity

Compare the Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of SAL023 and Italy-Manufactured Evenity in Healthy Subjects

A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis

Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis

A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.

Romosozumab in Women With Chronic SCI

Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI

Sequential Therapies After Osteoanabolic Treatment

Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis

A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With Osteoporosis

Romosozumab Versus Denosumab for Osteoporosis in Long-term Glucocorticoid Users

Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis

Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta